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INTRODUCTION
Urinary tract infections are the most common bacterial infections 
during  pregnancy  and  are  a  common  cause  of  serious  maternal  and 
perinatal  morbidity.  A  urinary  tract  infection  may  manifest  as 
asymptomatic  bacteriuria,  acute  urethritis  or  acute  cystitis  or 
pyelonephritis. With appropriate screening and treatment this morbidity 
can be limited.
Asymptomatic bacteriuria refers to persistent actively multiplying 
bacteria  within  the  urinary  tract  in  women  who  have  no  symptoms. 
Worldwide the incidence varies from 5-10% and depends on age, parity, 
race and socioeconomic status.
Urinary tract infections are the most common bacterial infections 
during pregnancy. They occur in same frequency in pregnancy as in non-
pregnant women. However the consequences of infection are far more 
serious during pregnancy warranting prompt diagnosis and treatment of 
infection.
With  extensive  study  of  asymptomatic  bacteriuria  since  1960 
following points seem to emerge.
1. 25  –  40%  of  pregnant  women  with  untreated  symptomatic 
bacteriuria are likely to develop acute pyelonephritis.
2. Untreated  convert  bacteriuria  has  been  associated  with  preterm 
delivery and low birth weight infant.
3. Increase in incidence of bacteriuria in low socioeconomic group 
women.
4. Screening and treatment of asymptomatic bacteriuria prevents most 
of the symptomatic urinary tract infections including pyelonephritis 
and decreases premature and low birth weight infants.
5. Women  with  recurrent  infections  and  failure  to  respond  to 
appropriate antibiotics show high incidence of abnormalities of the 
urinary tract.
Screening of all antenatal mothers for asymptomatic bacteriuria not 
only reduces the maternal and fetal morbidity but also identifies urinary 
tract abnormalities.
REVIEW OF LITERATURE
Among adults,  routine screening for  asymptomatic  bacteriuria is 
only indicated during pregnancy during pregnancy and prior to urologic 
surgery.
Symptomatic infections of the urinary tract in pregnancy are well 
recognized since the late 1800.
Dodd showed in 1931 that bacteria were present in the urine of 
11% of pregnant patients44.
Awareness  about  screening  and  treatment  of  asymptomatic 
bacteriuria  was  largely  unrecognized  until  mid  1950s.  In  1955 
quantitative approach to asymptomatic bacteriuria was followed.
Kass (1959) suggested that true bacteriuria could be separated from 
contamination by bacterial colony count of freshly obtained specimen of 
105 colony forming units/ml of urine48.
Pregnant women may frequently complain of symptoms such as 
lower abdominal pain, frequency, and dysuria. These symptoms are by 
themselves not diagnostic of UTIs. It is not routinely possible to separate 
women with significant bacteriuria from women with sterile urine based 
on symptoms alone.
Prevalence
Generally UTIs are 14 times more common in women than men. 
About  15% of women will  have a  UTI at  sometime  during their  life. 
Incidence of ABU varies from 2 – 7% during pregnancy (Williams 2000) 
depending on age, parity and socioeconomic status3.
According to Mudaliar, the incidence is 5 – 10%. The incidence 
raises with age, parity, low socioeconomic status, women with sickle cell 
trait, diabetes mellitus and past history of UTI.
The highest incidence is seen in African American multiparas with 
sickle cell trait and lowest incidence is in affluent white women of low 
parity3.
Age and parity
Kass 1960 reported increased incidence with age and parity. Little 
1960 and Priscilla 1968 reported increased incidence withy primigravidas 
and decreased incidence with age.
Hooton and colleagues 2000 – the prevalence of bacteriuria in non- 
pregnant  women is  5  –  6% and these  are  the same women in  whom 
bacteriuria is discovered during prenatal care2. Calvin et al – in preschool 
children bacteriuria is 10 – 20 times more common in girls of 5-6yrs than 
boys.
Socioeconomic status
Turck, Goffe, Petersdorf noted 2% incidence of 2% in middle and 
6.5% in lower socioeconomic group30. Kinlaid, Kaitz, Hodder indicated 
that socioeconomic factors influence the prevalence of bacteriuria6.
Relationship to marriage and sexual activity
Kunin and McCormack (1968) reported lower prevalence in nuns 
compared  to  matched  controls41.  Aberdeen  and  Chalmers  identified 
asymptomatic bacteriuria in 5 – 6% of married nulligravida and 6 – 8% in 
pregnant women.
The school years appear to be a reservoir of infection. Marriage 
and frequency of intercourse appear to be predisposing factor for UTI and 
increased further  by condom use.  These findings are explained by the 
mechanical effect of intercourse encouraging ascent of organisms up the 
urethra, an effect  that may be exacerbated by condom use particularly 
without lubricants5.
The risk of UTI is also increased by a change in sexual partner, 
which may reflect male to female transmission of uropathogens. Use of 
spermicides  as  an  adjunct  to  barrier  contraceptive  methods  is  also 
associated with an increased rate of periurethral colonization with E. Coli 
and other uropathogens, probably because nanoxynol – 9 is bactericidal 
against lactobacilli.
The protective effect of micturition soon after coitus is based on 
the supposition that washout of recently introduced bacteria will prevent 
establishment of infection5.
Vaginal and periurethral flora
Maintenance of an acidic pH by lactobacilli  present normally in 
vagina protects against colonization by uropathogens. Suppression of this 
normal vaginal flora by antibiotics or spermicide use increases the risk of 
vaginal and periurethral colonization with uropathogens and subsequent 
ascending UTI5.
Genetic factors
In  laboratory  studies  adherence  of  E.  Coli  to  both  vaginal  and 
buccal  cells  is  greater  in  women  with  recurrent  UTI  than  in  healthy 
controls.  Women  with  recurrent  UTI  more  frequently  have  gut 
colonization by uropathogens. 
This  difference  in  susceptibility  to  colonization  and  infection 
especially in patients in whom there is no other defect of host defense is 
due to genetically determine difference in extra cellular antigens to which 
bacteria adhere5.
Predisposing factors for ABU and symptomatic UTI
Pregnancy,  diabetes  mellitus,  single  catheterization,  indwelling 
catheter of more than 48hrs duration, cystocele, congenital and acquired 
obstructive urological disease, hydronephrolithiasis, sickle cell trait and 
use of broad spectrum antibiotics.
Normal changes in the kidney and urinary tract during pregnancy
Anatomical  changes begin  as  early  as  6  weeks  of  gestation  and peak 
during 22 – 24 weeks and remain till term and revert to normal by second 
month after delivery.
The most obvious changes is dilatation of the calyces, renal pelvis 
and ureter due to the smooth muscle relaxant effect of progesterone in 
early pregnancy and compression of ureter by the gravid uterus at the 
level of pelvic brim in the late pregnancy. Typically the ureteral dilatation 
and stasis is greatest during second and third trimesters.
Hypertrophy of circular muscle bundles at the lower end of 
ureter  has  been  proposed  due  to  hyperestrogenism.  All  these 
changes are more marked on the right side and more likely to 
occur in first  pregnancy and when pregnancies occur in rapid 
succession.
Bladder  decreases  in  tone  and  its  capacity  increases  due  to 
progesterone  so  that  in  late  gestation  it  can  contain  twice  its  normal 
contents without causing discomfort.
Physiological changes: 
- Renal blood flow and glomerular filtration rate increase by 
50 to 60%. 
- Blood urea, serum creatinine and serum uric acid decrease 
as a result of increased urinary excretion. 
- Urinary  excretion  of  glucose  increases  due  to  decreased 
tubular reabsorption.
Factors contributing to UTI during pregnancy
Normally bacteria introduced into urine are rapidly cleared by three 
naturally occurring defense mechanisms: 
- Neutrophils within the bladder wall phagocytose bacteria 
introduced into the urinary tract.
- Flushing effects of voiding.
- Inhibition  of  colonization  by  the  high  urea  content  and 
osmolality of urine.
Increased urinary stasis and vesicoureteric reflux due to decreased 
ureteral  and bladder tone and increased bladder volume.  70 – 90% of 
pregnant women develop glycosuria, which encourages bacterial growth 
in  urine.  Urinary  pH elevation  during  pregnancy  encourages  bacterial 
growth.  Increase  in  the  urinary  progestins  and  estrogen  may  lead  to 
decreased ability of lower urinary tract to resist invading bacteria. Animal 
experiments have shown that estrogen can enhance the growth of E. Coli 
strains that cause pyelonephritis. Renal medulla is particularly susceptible 
to  infection  because  its  hypertonic  environment  inhibits  leucocyte 
migration, phagocytosis and complement activity.
Causative organisms
A  few  species  of  bacteria  collectively  known  as  uropathogens 
account for most UTIs. Normally urine is sterile. Organisms introduced 
by contamination are frequently the same as those causing UTIs.
E. Coli  is  the most  common organism causing UTIs because of 
surface pili, which adhere to receptors on uro epithelial cells. It colonizes 
the distal urethra and vagina and perineal skin and contamination occurs 
during voiding and catheterization. (stuart et al 194) 8.
Data  from Millar,  Paul,  Wing  et  al  (2003)  show  the  following 
causative organisms9. 
Escherichia Coli 86%
Proteus mirabilis 4%
Klebsiella pneumonia 4%
Enterobacter 3%
Staph. Saprophyticus 2%
Other  less  common  organisms  include  streptococcus  agalactiae, 
Staph.  Aureus,  Gardnarella,  and  Ureaplasma  Urealyticum.  GBS 
bacteriuria is an indication for intrapartum chemo prophylaxis.
The  presence  of  a  non  uropathogenic  species  suggests  an 
abnormality of host defense.
Pathogenicity
Pathogenicity of E. Coli appears to be due to a number of factors 
including surface pili,  which adhere to uroepithelial cells,  resistance to 
vaginal  acidity,  rapid  division  in  urine,  adherence  to  cells  and  the 
production of  chemicals  which decrease ureteric peristalsis  and inhibit 
phagocytosis(Stein and Funfstuck 1999)32. 
The pathogenicity of Proteus species is due to motility - ability to 
ascend the urinary tract and that  of Staph. Saprophyticus is  due to its 
possession of a lactosamine adhesion molecule5.
Diagnosis
ACOG 2002 recommends that screening for all pregnant women 
for asymptomatic bacteriuria be done by urine culture at the first prenatal 
visit10.
The recommendation of US preventive Services Task Force is to 
obtain a urine culture between 12 – 16 weeks of gestation12.
The gold standard for screening for ABU is urine culture10.
Methods of collection of urine
Bacteria  very  easily  contaminate  urine  samples  during  voiding 
from the perineal skin resulting in false positive results.
In  women  the  reliability  of  urine  culture  can  be  improved  by 
collecting midstream sample. The women are instructed to wash hands 
and clean perineum with water and part the labia with one hand and to 
ensure collection of a midstream sample without either the initial portion 
or the after drip.
Urine is an excellent culture medium for bacteria and hence sample 
is immediately plated or refrigerated at 4’ C and sent to laboratory within 
4 hrs.
Pour  plate  method  is  the  most  precise  and standard  method  for 
urine culture.
Criteria for significant bacteriuria
Criteria vary according to method of collection and symptoms11.
In  asymptomatic  pregnant  women two consecutive  clean voided 
specimen more than 105 colony forming units of a single uropathogens 
per ml of urine. 
In symptomatic pregnant women colony count more than 103 CFU 
per ml of urine is significant.
Any  amount  of  growth  in  a  sample  obtained  by  supra  pubic 
aspiration is significant.
Other screening tests for bacteriuria
1. Microscopic examination for bacteria and pus cells.
2. Tests for bacterial products 
a) Nitrite (Griess test) nitrite reduction test
b) Catalase test
3. Screening test for pyuria – leucocyte esterase test.
Microscopic examination: Gram’s stain of urine is  an inexpensive 
method  but  it  is  not  used  as  a  screening  test  because  methodically 
reviewing the smears is too labor intensive.. Gram’s stain of centrifuged 
urine  offers  excellent  sensitivity  but  poof  specificity  and  is  not  an 
acceptable screening test for ABU11.
The false negative rates of urine analysis (19.4%) and reagent strip 
testing (52.8%) preclude these from being screening tests for ABU in an 
obstetric population. It is concluded that urine culture should be used for 
all pregnant patients11.
Griess  Test  (Nitrite  reduction  test):  The  rationale  is  that  most 
uropathogens are nitrate reducing. False positive results may occur – if 
the specimen is delayed in transit and overgrown with nitrate reducing 
bacteria. It is a rapid screening test taking 2 minutes to read by eye and 
pink color denotes positive test.
Limitations:  False negative results occur if the organism is non nitrate 
reducing (e.g. Enterococcus)  or  if  the patient is  on vegetable free diet 
(loss of an important source of nitrate) or if insufficient time has elapsed 
since the last void for nitrites to appear at detectable levels.
Leucocyte  esterase  test:  It  is  an  enzyme  produced  by  neutrophils.  A 
reagent  strip  is  used  to  detect  its  activity.  The  advantage  is  that  the 
leucocytes need not be viable for LE activity to be detected. 
False positive LE test may be due to high urinary levels of ascorbic acid 
or  albumin  level  of  more  than  300mg/dl  or  from  the  effects  of 
preservatives and detergents.
False negative LE test: when urine WBC counts are in the marginal range 
of 5-10/HPF, 
when correlated with >10WBC/HPF 
the sensitivity ranges from 70 to 84% and 
specificity ranges from 70 to 94%.
U.S.  Preventive  Services  Task  Force  (USPSTF  2000) 12 
recommends  that  screening  tests  for  ABU in  pregnancy  (dipstick  and 
direct microscopy) have poor positive and negative predictive values and 
urine culture is the gold standard for detecting ABU.
Urine culture is cost effective for routine screening in populations 
where the prevalence of asymptomatic bacteriuria is more than 2%. 
Catalase test: 
This  test  demonstrates  the  presence  of  catalase  an  enzyme  that 
catalyzes the release of oxygen from hydrogen peroxide. One ml of H2O2 
solution  is  poured  over  a  24hr  nutrient  agar  slope  culture  of  the  test 
organism and the tube is held in a slanting position.
The production of gas bubbles from the surface of the solid culture 
material indicates a positive test. It almost occurs immediately. A false 
positive reaction may be obtained if the culture medium contains catalase. 
(e.g.  blood  agar)  or  if  an  iron  wire  loop  is  used.  This  test  offers  no 
advantage over other tests. It functions similarly to nitrite test and suffers 
from same defects.
Table1
Screening test sensitivity Specificity
Positive 
predictive 
value
Negative 
predictive 
value
Catalase test 70(+/- 13.5) 45(+/- 5.5) 14(+/- 5) 92(+/- 4)
Nitrite test 45(+/- 15) 97(+/- 2) 63(+/- 17.5) 93(+/- 2.5)
Pyuria 67(+/- 16) 80(+/- 5.5) 30(+/- 9) 95(+/- 2.5)
LE test 69(+/- 14) 69(+/- 5) 22(+/- 6) 95(+/- 2.5)
Bacteria 93(+/- 8) 43(+/- 5.5) 18(+/- 4.5) 98(+/- 2.5)
Dipstick (LE + Nitrite 
test) 81(+/- 12) 97(+/- 2.2) 24(+/- 7) 97(+/- 2.2)
Microscopy (Pyuria + 
Bacteriuria) 93(+/- 8) 42(+/- 5.5) 17(+/- 4.5) 98(+/- 2.5)
Results of rapid screening tests compared with urine culture.                 
(Millar et al Obstet. & Gynecol.Vol:95:601, 2000)
The combination of leucocyte esterase and nitrite tests has better 
sensitivity  and  specificity  in  detecting  asymptomatic  bacteriuria  than 
either test alone.
URINE CULTURE SHOWING GROWTH OF E.COLI
URINE CULTURE SHOWING GROWTH OF 
KLEBSIELLA.PNEUMONIAE
GROWTH OF STAPHYLOCOCCUS AUREUS ON BLOOD AGAR
Significance of asymptomatic bacteriuria in pregnancy
Acute pyelonephritis: 
20 – 40% of untreated asymptomatic bacteriuric women develop 
acute pyelonephritis and these women are at increased risk for preterm 
delivery and low birth weight infants.10,12,13,16.18,19.21,22,25,29,43.
Acute pyelonephritis occurs in 1 – 2% of all pregnancies and is the 
most common non-obstetric cause for hospitalization during pregnancy. It 
is the most common serious medical complication of pregnancy that can 
progress to maternal sepsis syndrome, preterm labor and delivery, renal 
dysfunction in 20%, adult respiratory distress syndrome in 1-2% due to 
endotoxin  induced  alveolar  capillary  membrane  injury  and  endotoxin 
induced acute hemolysis(one third of these women develop acute anemia) 
and bacteremia in 20%.
Clinical manifestations of acute pyelonephritis usually occur 24 to 
48hrs after the patient is admitted. Towers et al found pulmonary injury 
in  11  of  130  patients  with  pyelonephritis49.  Some  of  these  patients 
required  endotracheal  intubation,  mechanical  ventilation  and PEEP.  A 
fever of greater than 103’F, heart rate more than 110bpm and a gestation 
greater than 20weeks placed the patients at increased risk for pulmonary 
injury.  In  his  study  the  most  predictive  factors  for  ARDS were  fluid 
overload and tocolytic therapy.
The diagnosis of acute pyelonephritis is made when bacteriuria is 
accompanied  by  abrupt  onset  of  systemic  symptoms  or  signs  such  as 
fever, rigor, nausea, vomiting, flank pain which is usually right sided and 
bilateral  in  25%.  Urine  microscopy  shows  numerous  bacteria  and 
leucocytes.
The management of pregnant woman with acute pyelonephritis3:
1. Hospitalization
2. Urine and blood cultures
3. Hemogram, serum creatinine and electrolytes
4. Monitor  vital  signs  frequently  including  urine  output;  consider 
indwelling catheter.
5. IV crystalloid to establish urine output to 30ml or more/hr
6. IV antimicrobial therapy
7. Chest X ray if there is dyspnea or tachypnea.
8. Repeat hematology and chemistry studies in 48hrs
9. Change to oral antimicrobials when afebrile
10.Discharge when afebrile 24hrs; Oral antimicrobials continued for 
7-10days
11. Urine culture 1-2weeks after antimicrobial therapy completed.
IV antibiotics for acute pyelonephritis include 
1. Inj. Ceftriaxone 1 to 2 g every 24hrs
2. Inj. Cefotaxime 1 to 2 g every 12hrs
3. Inj. Cefazoline 1 to 2 g every 8hrs
4. Inj. Aztreonam 1 g every 8hrs
5. Inj. Ampicilling 1 to 2 g every 6hrs with gentamicin 1mg/kg every 
8 hours
Acute cystitis in pregnancy:
It  is  a  distinct  clinical  entity.  The  diagnosis  of  acute  cystitis  is 
based on urinary urgency, frequency, dysuria and suprapubic pain and 
tenderness  in  the  absence  of  systemic  symptoms  such  as  fever  and 
costovertabral  angle  tenderness.  Gross  hematuria  may  be  present;  the 
urine culture is invariably positive for bacterial growth. It is important to 
recognize that only about 50% of women presenting with dysuria or other 
lower urinary tract symptoms will have bacteriologic confirmation of a 
urinary  tract  infection.  Those  cases  with  symptoms  of  urinary  tract 
infection but without bacteriologic evidence of infection are called the 
acute  urethral  syndrome,  which  is  in  many  instances  associated  with 
chlamydial  infection.  Thus  bacterial  conformation  is  crucial  to 
establishing a diagnosis of acute cystitis. Traditionally quantitative urine 
cultures were the gold standard and greater than 1lakh colonies per ml of 
urine, the significant  count.  Mucopurulent  cervicitis  often coexists and 
erythromycin therapy is effective. 
Recently Stamm and coworkers suggested that in acutely dysuric 
patients a count of 100 colonies or more per ml is significant.
Women  with  cystitis  respond  readily  to  any  of  the  several 
regimens.  As with covert  bacteriuria,  a  three-day course  of  therapy is 
usually 90% effective. 
Bacteriuria and hypertension:
An increased incidence of hypertensive disorder of pregnancy has 
been alleged in pregnant women with ABU; such a relationship has been 
the subject of much controversy. Although some studies have confirmed 
this postulate41,42,43, in general , most workers have failed to document any 
association  between  bacteriuria  and  hypertension45,46,47.  Moreover  the 
studies  supporting  an  association  between  bacteriuria  and  gestational 
hypertension  have  reported  conflicting  results  about  whether  or  not 
eradication  of  bacteriuria  by  antimicrobial  treatment  reduces  the 
incidence  of  hypertensive  disease  of  pregnancy  among  bacteriuric 
women41,47.  In addition to demonstrating that there was no relationship 
between ABU in pregnant women and preeclampsia. Gilstrap et at found 
no difference in the pyelonephritis group versus their controls with no 
UTI50.
Schieve  et  al  (1994)  found  increased  risk  for  hypertension  or 
preeclampsia and maternal anemia. 
Chazan  et  al  2003  reported  a  reduction  in  the  incidence  of 
hypertension in the treated group39. 
A  Cochrane  review  2000  reported  no  increased  risk  for 
hypertensive  disorders  in  bacteriurics  compared  to  general  obstetric 
population13. When evidence of previous parenchymal damage is present, 
however there may be a greater propensity to hypertension (McGladdery 
et al)34.
At  present  an association  between asymptomatic  bacteriuria  and 
hypertensive disorders of pregnancy is questionable.
Bacteriuria and preterm delivery and low birth weight infants:
Pregnant  women  who  develop  acute  pyelonephritis  are  at  a 
significantly increased risk for preterm labour and delivery. In contrast 
the  relationship  of  ABU  to  preterm delivery,  low birth  weight,  SGA 
babies and fetal mortality has been controversial. 
In  1959  Kass  reported  that  the  prematurity  is  24%  in  placebo 
treated group and 8% in bacteriuric patients treated with antibiotics1. He 
noted that prematurity rate was two to three times greater in bacteriuric 
women receiving a placebo than in non bacteriuric women or patients 
whose bacteriuria has been eliminated. Gruneberg and co workers noted 
that an increased rate of prematurity and decrease in their infants’ birth 
weight occurred in those bacteriuric women who were either refractory to 
treatment or in whom bacteriuria had recurred46.
Some investigations have reported that bacteriuric patients who do 
not respond to treatment are likely to have subclinical renal involment42. 
These data have been used to support the hypothesis that women with 
subclinical renal involvement are the population at risk to deliver preterm 
or  low  birth  weight  infants.  Romero  1993  found  strong  correlation 
between asymptomatic bacteriuria and low birth weight and showed that 
treatment decreases its occurrence19. 
Christensen 2000 reported that treatment of bacteriuria decreases 
incidence  of  pyelonephritis  and  preterm labor  to  1  –3%  whereas  the 
reported prevalence in untreated patients is 20-40%.
A  Cochrane  metaanalysis  2002  showed  decreased  incidence  of 
pyelonephritis,  preterm  delivery  and  low  birth  weight  infants  with 
effective treatment of asymptomatic bacteriuria13. Many variables affect 
prematurity  and bacteriuria  is  only  one  of  the  many  factors  that  may 
influence  the  onset  of  premature  labour.  As  the  incidence  of  both 
pregnancy  bacteriuria  and  prematurity  increases  with  decreasing 
socioeconomic  status,  any  relationship  between  bacteriuria  and 
gestational  length  and  birth  weight  may  be  complex  and  difficult  to 
establish.
Evidence of transfer of infection from mother to fetus: 
Certain bacteria including E.  Coli  are  known to stimulate  blood 
group  antibodies.  Recent  studies  have  shown  an  increase  in  titre  of 
isohaemagglutinins  in  the  infants  of  mothers  with  E.  coli  bacteriuria. 
Lymphocytes of infants of mothers with E. coli infection show blast cell 
transformation when cultured in the presence of E. coli antigen extract. It 
appears  that  asymptomatic  bacteriuria might  result  in dissemination  of 
organisms to the maternal circulation to intervillous space to fetus.
Patrick demonstrated E. coli in amniotic fluid, placenta, umbilical 
cord of infants of mothers with bacteriuria. 
Treatment of asymptomatic bacteriuria in pregnancy:
Since at a minimum bacteriuria predisposes the pregnant women to 
acute  pyelonephritis,  it  is  a  potential  hazard  to  the  fetus.  Thus  the 
detection  and  treatment  of  ABU  provides  the  obstetrician  an  ideal 
opportunity to prevent a significant medical complication of pregnancy. 
The aim of therapy is to eradicate bacteriuria and decrease the incidence 
of complication.
Selection criteria of antimicrobial drug:
- the drug should be safe for both mother and fetus
- the drug should be bactericidal
- the drug should address the common infective organisms 
(gram –ve enteric bacilli)
Majority  of  the  antimicrobial  drugs  are  excreted  by  glomerular 
filtration and as a result therapeutic concentrations are readily achieved in 
urine. In fact the concentrations of these drugs in the urine greatly exceed 
those required for the treatment of most UTIs. Even drugs that do not 
have a therapeutic concentration in the serum such as nitrofurantoin are 
present  in  significant  concentrations  in  urine.  The  drug  selected  must 
have the  narrowest spectrum of activity so that indigenous microflora of 
intestine and vagina avoided to prevent development of candiidasis.
Duration of treatment:
Conflicting  evidence  remains  about  shorter  course  or  7-10days 
course. A 7 – 10 day course is usually sufficient to eradicate the infecting 
organisms. 
A  Cochrane  Systematic  review 2000  included  five  regimens  of 
antibiotic  treatment  and  concluded  that  there  were  no  significant 
differences  between  any  of  the  regimens  studied  and  was  unable  to 
recommend any particular regimen13.
In general the results of single dose therapy appear to be inferior to 
those of longer course of therapy. 
Antimicrobial  agents  used  for  treatment  of  pregnant  women  with 
asymptomatic bacteriuria(Williams et al 2000)  3 . 
Single dose therapy:
Amoxycillin 3g
Ampicillin 3 g
Cephalosporin 2 g
Nitrofurantoin 200mg
Fosfomycin 3 g
Three-day course:
Amoxycillin 500mg tds
Ampicillin 250mg qid
Cephalosporin 250mg qid
Nitrofurantoin 100mg bd
Trimethoprim / Sulphamethoxazole 160/800 mg bd
7 to 10-day course:
Amoxycillin 500mg tds
Ampicillin 250mg qid
Cephalexin 250mg qid
Nitrofurantoin 100mg HS
Treatment failures:
Nitrofurantoin 100mg qid X 21 days
Suppression for bacterial persistence or recurrence:
Nitrofurantoin 100mg HS or Cephalexin 250mg HS for remainder 
of pregnancy.
Recurrence rate reported for all the regimes is 30%. UTIs recur in 4 
–5% of pregnancies. The risk of developing pyelonephritis is the same as 
the risk with primary UTIs18. 
Side effects of antibiotics during pregnancy
Sulphonamides : Avoided  in  the  third  trimester  due  to  risk  of 
kernicterus especially  in preterm infants  since it 
may bind to bilirubin binding sites on albumin.
Trimethoprim : Interferes with neural tube development.
Nitrofurantoin : When given in the last  few weeks of pregnancy 
risk of hemolysis in case of G6PD deficient fetus.
Aminoglycoside
s
: Nephrotoxic and ototoxic
Fluroquinolones : Interfere with cartilage formation
Pencillins,  Cephalosporins,  beta  lactamase  inhibitors, 
monobactums, fosfomycin are safe during pregnancy.
The  effectiveness  of  therapy  for  ABU  is  best  documented  by 
Harris’ report of decreased incidence of pyelonephritis in their institution 
after a screening programme had been implemented52. The incidence of 
pyelonephritis was reduced from 2.5% of all obstetric admissions in 1974 
to 0.5% in December 1978. A similar dramatic decrease in the incidence 
of  pyelonephritis  in  pregnancy following the introduction of  a  routine 
screening  programme  for  ABU  was  noted  at  Parkland  Memorial 
Hospital53.  This  occurred  despite  no  decrease  in  the  incidence  of 
bacteriuria. Gratacos and coworkers recently reported a sharp reduction in 
the incidence of pyelonephritis (1.8 to 0.6%, p < 0.001) following the 
introduction  of  a  programme  to  screen  and  treat  ABU  in  pregnant 
women54.
Indications for postpartum urologic evaluation:
1. In patients with recurrent infections since they are more likely to 
have structural abnormalities of urinary tract.
2. In patients who have a recurrent urinary tract infection while on 
suppressive antibiotic therapy (Schwartz et al 1999).
Long term prognosis
20 – 65% of untreated patients clear their bacteriuria in the first 
postpartum year. Stuart et al 1984 found that there is no evidence to show 
that asymptomatic bacteriuria causes permanent renal damage or alter the 
lifespan of the patients43.
AIMS OF THE STUDY
1. To find out the prevalence of asymptomatic bacteriuria in antenatal 
women at their first antenatal visit.
2. To  know  the  association  of  bacteriuria  with  age,  parity  and 
socioeconomic status.
3. To know the common causative organism and treatment response 
to antibiotics
4. To  find  whether  the  incidence  of  symptomatic  UTIs,  preterm 
delivery and low birth  weight  infants  decreases  by  treatment  of 
asymptomatic bacteriuria
5. To  find  the  correlation  between  asymptomatic  bacteriuria  and 
hypertensive disorders of pregnancy and maternal anemia.
MATERIALS AND METHODS
During  the  period  from  September  2006  to  August  2007,  500 
antenatal women between 12 to 16 weeks of gestation attending antenatal 
O.P. at Women and Children Hospital, Egmore were randomly selected. 
All the women were instructed to wash hands and clean perineum with 
water and to part the labia with one hand and to collect midstream urine 
sample  without  either  the  initial  portion  or  the  after  drip.  Thus  clean 
voided  midstream  urine  sample  was  collected  and  sent  to  laboratory 
within 2 hrs. 
The urine sample of each patient was tested for the presence of 
nitrite by dipstick and one portion was sent for routine urine analysis and 
another  portion  sent  for  culture  and  sensitivity  and  colony  count. 
Occurrence of pink color in the dipstick at the end of 2 minutes indicated 
positive nitrite test. Colony count of more than one lakh colony forming 
units  of  a  single  uropathogens  per  ml  was  taken  as  diagnostic  of 
asymptomatic bacteriuria.
Treatment was given to all patients with significant bacteriuria with 
oral cephalexin 500mg bd X 7days. Urine culture was repeated one week 
after  completion  of  treatment.  Two  patients  had  persistant  bacteriuria 
were  treated  with  Inj.  Gentamicin  80mg bd X 5days  and  then  repeat 
cultures were negative.
Both bacteriurics and non bacteriurics were followed at monthly 
intervals. They were examined for clinical parameters like weight gain, 
blood pressure  and complete  hemogram,  rountine urine analysis  blood 
urea, sugar and serum creatinine. For all treated patients urine culture was 
repeated once in late second trimester  and once in third trimester.  For 
other  patients,  urine  culture  was  repeated  once  in  third  trimester.  All 
patients were followed up to delivery and discharge. The occurrence of 
acute symptomatic urinary tract infections (pyelonephritis and cystitis), 
preterm labor and delivery, hypertensive disorders and maternal anemia 
and  low birth  weight  infants  were  noted.  The  perinatal  outcome  was 
studied.
Inclusion criteria
1. Pregnant women between 12 to 16 weeks of gestation irrespective 
of parity.
2. The pregnant women randomly selected had no symptoms or signs 
of UTI.
3. All women had normal BP.
4. Unskilled laborers on unfixed wages were considered to belong to 
socioeconomic class V. Skilled and semiskilled workers on fixed 
wages were considered class III and IV respectively.
5. In the absence of symptoms colony count of 105 or more colony 
forming units per ml of urine was taken as significant bacteriuria.
Exclusion criteria:
1. Pregnant women taking antibiotics for any reason were excluded.
2. Antenatal  women  with  symptoms  of  UTI  such  as  frequency, 
urgency, dysuria and supra pubic pain were excluded.
3. During  the  study  women  who were  found  to  have  hydramnios, 
multiple  pregnancy,  placenta  praevia,  congenital  anomalies  were 
excluded from the study.
4. Patients  with  anemia  and hypertension  at  the  first  prenatal  visit 
were excluded.
RESULTS AND OBSERVATIONS
Table 1. DISTRIBUTION OF ASYMTOMATIC BACTERIURIA
S No Description No of cases Percentage
1
Urine culture positive 
(Bacteriurics)
54 11.73
2
Urine culture negative 
(Nonbacteriurics)
406 88.26
In this study the incidence of asymptomatic bacteriuria in antenatal 
women at their first prenatal visit was found to be 11.73%
Table 2. DISTRIBUTION IN DIFFERENT AGE GROUPS
S No Age group Total no of cases
No of 
bacteriurics Percentage
1 15 – 19yrs 98 7 7.14
2 20 – 29 yrs 271 43 15.86
3 30 – 39 yrs 91 4 4.39
X2 test = 6.455 p = < 0.05
The incidence is more common in the age group of 20-29 years, 
which may be related to peak sexual activity in this age group, and it is 
statistically significant.
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Table 3. DISTRIBUTION IN DIFFERENT GRAVIDA
S No Gravida Total no of cases
No of 
bacteriurics Percentage
1 Primi 286 39 13.63
2 G2 115 10 8.69
3 G3 & above 59 5 8.47
Maximum cases of bacteriuria occur in primigravida. This may be 
related  to  peak  sexual  activity  and  lack  of  knowledge  about  hygienic 
habits during sexual activity delayed post coital micturition.
Table 4. SOCIOECONOMIC STATUS
S No
Socio 
economic 
status
Total no of 
cases
No of 
bacteriurics Percentage
1 Class V 346 44 12.71
2 Class III & IV 114 10 8.77
There  is  a  high  incidence  of  ABU in  the  lower  socioeconomic 
group due to lack of knowledge, low literacy and poor personal hygiene 
and lack of facilities to maintain hygiene.
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Table 5. PAST HISTORY OF URINARY TRACT INFECTION
S No Gravida Total no of cases
No of 
bacteriurics Percentage
1 Primi 40 8 20
2 G2 24 6 25
3 G3 & above 18 5 27
X2 = 0.172 p > 0.05
Previous  urinary  tract  infection  is  a  significant  risk  factor  for 
asymptomatic bacteriuria during current pregnancy regardless of parity. 
Previous  UTI  may  cause  subtle  renal  damage  that  may  be  unmasked 
during pregnancy.
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Table 6. RECURRENT SYMPTOMATIC UTI
S No Prenatal visit
No of 
bacteriurics Percentage
1 First visit 54 0
2 Late 2
nd 
trimester 2 3.7
3 3
rd 
trimester 4 7.4
Out of treated bacteriuric patients 2 women in late second trimester 
and 4 in third trimester developed symptoms of acute cystitis and culture 
was  positive  for  E.  coli  and  all  6  women  were  treated  with  oral 
cephalexin  500mg  bd  X7days.  None  of  the  patients  in  both  groups 
developed pyelonephritis.
Table 7.  URINE NITRITE DIPSTICK TEST
S No Description
Nitrite 
positive
%
Nitrite 
negative
%
1 Bacteriurics 40 74.07 14 25.92
2
Non 
bacteriurics
8 2 398 98
The sensitivity of this test is 74% and false negative rate is more 
than 25%. When this test alone was used for screening about one fourth 
of the bacteriurics would have been missed.
Table 8. URINE ANALYSIS
S No Description
Total No of 
of cases 
among 
bacteriurics
Nonbacteriurics
1 Proteinuria 24 (44%) 36 (9%)
2 Pyuria 34 (63%) 16 (4%)
Proteinuria is increased during pregnancy and levels upto 300mg/dl 
are considered normal. It is increased during UTI because of release of 
protein from leucocytes. Leucocyte excretion is increased in bacteriurics.
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Table 9. CAUSATIVE ORGANISMS
S No Organisms No of  of cases Percentage
1 E. coli 49 90.7
2 Klebsiella 4 7.4
3 Staph. aureus 1 1.85
The  most  common  causative  organism  is  Escherichia  coli 
accounting for 90% of cases. The organisms are usually gram negative 
enteric bacilli. These are collectively called as uropathogens.
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Table 10. ANTIBIOGRAM
Historically ampicillin has been the drug of choice but in recent 
years E. coli has acquired resistance to ampicillin. In this study there is 
71% sensitivity of E. coli to ampicillin. Alternatively the cephalosporins 
are well tolerated and adequately eradicate the common organisms.
Organism No of isolates Cipro Norflox Cef Ami Gara Ampi
E. coli 49 49(100%)
49
(100%) 47 (97%)
49
(100%) 48 (98%) 35 (71%)
Klebsiella 4 4 (100%) 3 (75%) 4 (100%) 4 (100%) 3 (75%) 2 (50%)
Staph. 
Aureus 1 1 (100%) 1 (100%) 1 (100%) 1 (100%) - -
Table. 11 DISTRIBUTION OF ANEMIA
S No
Hb in 
gm%
Non bacteriurics Bacteriurics
1 > 10 274 67.48% 35 64.81%
2 < 10 132 32.51% 19 35.18%
X2 = 0.154 p > 0.05
The  incidence  of  anemia  in  bacteriuric  group  is  35%  and  in 
nonbacteriurics it is 32%.  The difference is not statistically significant.
Table 12. DISTRIBUTION OF PREECLAMPSIA
S No Description Total no of cases
No of cases 
preeclampsia Percentage
1 Bacteriurics 54 5 9.25
2 Non bacteriurics 406 35 8.62
X2 = 0.024 p > 0.05
The occurrence of preeclampsia among bacteriurics is comparable 
to  that  of  non  bacteriurics  and  the  difference  is  not  statistically 
significant.
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Table. 13  MODE OF DELIVERY
S No Description Non bacteriurics Bacteriurics
1
Labour 
natural
278 68% 38 74%
2 Forceps 18 4% 2 4%
3 LSCS 110 27% 12 22 %
X2 = 0.248 p > 0.95
The difference in the number of operative deliveries in bacteriurics 
treated with antibiotics and nonbacteriurics is not statistically significant. 
IUGR was present in woman with bacteriuria and the postnatal outcome 
was good.
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Table 14. FETAL OUTCOME
S No Gestational age at delivery Bacteriurics Nonbacteriurics
1 37 completed weeks and above 48 (88.7%) 378 ( 89.4%)
2 34 weeks to 36.6 weeks 6 (9.2%) 25 ( 8.6%)
3 28 weeks to 33.6 weeks 0 3 ( 0.7%)
X2 = 0.14 p > 0.05
There were no cases of preterm delivery in the bacteriuric pregnant 
women treated with antibiotics between 28 to 34 weeks and all five cases 
of preterm deliveries were between 34 to 37 weeks of gestation whereas 
there were 3 cases of preterm deliveries between 28 to 34 weeks and 25 
cases  after  34  weeks  in  non  bacteriuric  women.  The  difference  is 
statistically not significant.
Table 15. DISTRIBUTION OF LOW BIRTH WEIGHT
S No Birth weight Bacteriurics Nonbacteriurics
1 1 to 1.5kg 0 (0%) 4 ( 1%)
2 1.6 to 2.4kg 9 (16.6%) 50 ( 12.3%)
3 2.5 to 2.9kg 40 (74.1%) 242 ( 59.6%)
4 3 kg & above 5 (9.2%) 110 ( 27.1%)
X2 = 2.022 p > 0.3
The occurrence of low birth weight infants appears to be higher in 
bacteriuric  women  treated  with  antibiotics  and  all  infants  weighed 
between 1.6 to 2.4kg. The difference in low birth weight infants in both 
groups is not statistically significant. There were three neonatal deaths in 
nonbacteriuric group all less than 1.5kg and all the deaths were due to 
respiratory distress syndrome.
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DISCUSSION
Out  of  the  500  pregnant  women  screened  at  12-16  weeks  of 
gestation 460 women were taken for statistical analysis. The distribution 
of asymptomatic bacteriuria among these women is 11.73%.
Incidence   
According to Mudaliar, the incidence of ABU varies between 5 – 
10%. The incidence of bacteriuria during pregnancy varies from 2- 7% 
depending  on  age,  parity,  race  and  socioeconomic  status  (Williams 
2002)3. In this study the incidence is 11.7% which may be related to low 
socioeconomic status.
Age and parity
Initially  Kass  showed that  frequency of  ABU during pregnancy 
increases  with  age  and  parity.  Little  and  priseilla  reported  decreasing 
incidence with age and increased incidence in primigravidas. Hooton and 
colleagues reported that prevalence of bacteriuria in non pregnant women 
is 5-6% and these are the same women in whom bacteriuria is discovered 
during prenatal care2.
The physiological  changes of ureteral and renal pelvis dilatation 
are  more  pronounced during  first  pregnancy  and less  marked  changes 
lead  to  reduced  incidence  in  multigravida   (Manndess,  Douglass  and 
Bennets 2004)7.
This study correlates with these findings in that the incidence is 
more in primigravidas (13.6%) and in the age group of 20 – 29 years 
(15%)  attributed  to  peak  sexual  activity,  which  favors  periurethral 
colonization with enteric bacilli.
Socioeconomic status
Women  from  lower  socioeconomic  groups  have  a  higher 
prevalence of UTI in pregnancy ( Brenner – The Kidney 2004)  22.ABU 
during  pregnancy  is  more  common  in  women  in  low  socioeconomic 
status (Williams 2003)  3.  A Cochrane Database Systematic review has 
shown  that  asymptomatic  bacteriuria  may  be  marker  for  low 
socioeconomic status, which is associated with low birth weight.
This study correlates with these findings in that the incidence in 
low socioeconomic groups is 12.7% reflects the importance of literacy, 
health awareness and personal hygiene in the prevention of UTIs.
Past History of urinary tract infection:
Women  with  a  history  of  bacteriuria  during  childhood  have  an 
increased frequency of UTI during pregnancy compared with pregnant 
women with no previous history of bacteriuria (  Paller and Connaire). 
The possibility that asymptomatic bacteriuria during childhood results in 
subtle renal damage that can be unmasked during pregnancy is suggested 
by  the  finding  that  GFR  increased  less  in  such  women  during 
pregnancy22.
In this study past history of UTI and treatment with antibiotics was 
present  in  40 primigravidas  and 20% of  these  women had bacteriuria 
during pregnancy and 25% of second gravidas and 27% of third gravidas 
with past UTI had ABU during pregnancy. P value is more than 0.05 and 
the difference is statistically not significant.
Recurrent infection:
The UTIs in pregnancy recur in 4 – 5% of pregnancies even with 
appropriate treatment. The risk of developing pyelonephritis is the same 
as the risk with primary UTIs ( John E. Delzell and Michael L. Lefevre 
2000)18. ACOG 2002 and American Academy of Pediatrics recommend 
that a urine culture be obtained at the first visit and a repeat urine culture 
in the third trimester because the urine of treated patients may not remain 
sterile for the entire pregnancy10.
30  – 40% of  the  pregnant  women with  untreated  asymptomatic 
bacteriuria later have pyelonephritis compared to 3% in those treated with 
antibiotics ( Christensen 2000; Sweet 1977).
A Cochrane Database Systematic Review (2000) has shown that 
drug  treatment  of  asymptomatic  bacteriuria  in  pregnant  women 
substantially reduces the risk of pyelonephritis13.
Correlating with these studies with the present study, there were no 
cases of pyelonephritis in both groups and there were 2 cases of acute 
cystitis  in  second  trimester  and  4  cases  in  third  trimester.  The  urine 
cultures  were  positive  for  E.  coli  and  all  patients  responded  to  oral 
cephalexin 500mg bd X 7days.
Urine nitrite test
Bachman  and  associates  (2000)  compared  dipstick  leucocyte 
esterase and nitrite tests with urine culture and found only one half of 
patients with bacteriuria were identified with dipstick tests.
Rouse and colleagues (2002) 14 performed a cost benefit analysis of 
screening for bacteriuria in pregnant women versus in patient treatment of 
pyelonephritis  and  found  a  substantial  decrease  in  overall  cost  with 
screening for ABU.
In a prospective study for evaluation of reagent strips in detecting 
ABU  in  early  pregnancy  in  Liverpoo  Women  Hospital  1998,  it  was 
concluded that urine dipstick tests are not sensitive enough to be used for 
screening  and  that  many  patients  would  be  missed20.  A  Cochrane 
Database  Systematic  Review 2000 recommends  formal  bacteriological 
culture as the gold standard for screening for ABU.
In  this  study  nitrite  test  was  positive  in  only  40  patients  with 
bacteriuria. Sensitivity was 74%. If this test alone was used for screening 
more than one fourth of cases would have been missed.
Proteinuria is increased in UTI as a result  of release of proteins 
from leucocytes but is neither sensitive nor specific5,22. Pyuria defined as 
more than 5-7 pus cells per high power field in pregnant women more 
often indicates urinary tract infection rather than colonisation22.
In this study pyuria was present in 62% of bacteriurics and 16% of 
nonbacteriurics.
Causative organisms
Data  from  Rubin,  Beam,  and  Wing  et  al  show  that  the  most 
common  isolate  is  E.  coli  and  other  organisms  included  proteus, 
Klebsiella, Staph. Aureus and saprophyticus and enterococcus.
In this study E. coli is the most common organism accounting for 
90% of  cases  and  Klebsiella  was  isolated  from 4  patients  and  Staph. 
Aureus in one patient.
Antibiotic sensitivity
A Cochrane systematic review 2000 studied 5 regimens and was 
unable to recommend any particular regimen13.
Resistance to ampicillin was found in 20 – 30% of cases of E. coli 
infection  18.  Masterton  1998  demonstrated  a  cure  rate  of  88% with  a 
single dose of ampicillin. Several other studies have shown single dose of 
any drug to be less successful with cure rate of 50 – 78%. Hence a 3 or 7-
day course is recommended by most. 
In this study the sensitivity  of E.  coli  to ampicillin  is  71%. All 
gram negative bacilli and Staph aureus were sensitive to cephalosporins 
and quinolones.  All  patients  were treated  with oral  cephalexin 500mg 
bdX 7days since quinolones are contraindicated in pregnancy. 2 patients 
had  repeat  cultures  positive  for  E.  coli  and  were  treated  with   Inj. 
Gentamicin 80mg bd X 5days. Both these drugs were well tolerated.
ABU and anemia and preeclampsia
Schieve et al 1994 studied 27746 pregnant women and found that 
UTI during pregnancy was associated with premature labor, hypertensive 
disorders of pregnancy, anemia and amnionits15.  But this study did not 
prove  cause  and  effect  relationship.  Several  others  have  attempted  to 
relate  asymptomatic  bacteriuria  to  development  of  hypertensive 
disorders, but the results have been unclear.
In this study anemia was present in 32.5% in non bacteriurics and 
35.18% of bacterirurics. p value is more than 0.05 and the difference is 
not statistically significant. Five patients among  bacteriurics developed 
preeclampsia  (  9.25%  )  whereas  8.62%  of  nonbacteriurics  developed 
preeclampsia. p value is more than 0.05. The difference is not statistically 
significant.
ABU and premature delivery and low birth weight infants
Treatment of ABU during pregnancy at the first prenatal visit in 
early  gestation  decreases  the incidence  of  premature  delivery  and low 
birth weight and its associated perinatal mortality1, 3, 5, 7, 10,13. 
In this study the incidence of preterm delivery in non bacteriurics 
was 8.65% and in bacteriurics treated with antibiotics was 9.25%. p value 
is more than 0.05 and the difference is not statistically significant.
The incidence of low birth weight is 16.6% in bacterirurics treated 
with antibiotics and 13.3% in non-bacteriurics. The p value is more than 
0.3 and the difference  is  not  statistically  significant.  There were three 
neonatal deaths in non bacteriuric group with birth weight between 1 to 
1.5kg. There was no neonatal mortality in the bacteriuric group. 
This  study  correlates  with  above  studies  in  that  the  antibiotic 
treatment  of  asymptomatic  bacteriuria  during  pregnancy  substantially 
reduces the incidence of preterm delivery and low birth weight infants 
comparable to that of non  bactetriurics.
SUMMARY
500  antenatal  women  attending  antenatal  O.P.  at  Women  and 
Children Hospital, Egmore, Chennai were screened for ABU at the first 
prenatal visit between 12-16 weeks of gestation during the period from 
September  2006  to  August  2007  with  quantitative  urine  culture.  Five 
patients  who  were  found  to  have  hydramnios,  multiple  pregnancy, 
placenta praevia and congenital anomaly of fetus were excluded from the 
study. 35 women were lost during followup. 460 women were taken into 
account  for  statistical  analysis.  Both  bacteriurics  and  non  bacteriurics 
were  followed  upto  delivery  and  the  adverse  effects  of  bacteriuria  in 
mother  and  neonate  were  observed  and  analyzed.  The  results  are 
summarized as follows:
The incidence of ABU in the study group was 11.73% attributed to 
low socioeconomic status of the women.
Screening  at  the  first  antenatal  visit  54  pregnant  women  were 
found to be culture positive for bacteria and most were in the age group 
of 20 – 29 years ( 15.8%) and most were primigravida (13.6%) which 
may be related to early marriage and peak sexual activity which favors 
periurethral colonization of bacteria.
Among the bacteriurics 70% were primigravidas. This shows that 
these women might have had bacteriuria even before marriage, which has 
been unmasked by pregnancy changes in the urinary tract.
Among the bacteriurics 80% belonged to socioeconomic class V an 
important association found in literature.
A significant proportion of patients had past history of urinary tract 
infection and treatment with antibiotics.
Nitrite test was positive in only 94% of bacteriurics suggesting that 
it is not sensitive enough to be used as sole screening test.
Pyuria  was  present  in  62%  of  bacteriurics,  which  cleared  after 
antimicrobial  treatment  suggesting  infection  than  mere  colonization. 
Acute cystitis developed in 6 women among bacteriurics and 4 women in 
non-bacteriuric group. No cases of pyelonephritis occurred in both groups 
suggesting  that  early  screening  and  treatment  of  ABU  is  essential  in 
preventing this complication.
E.  coli  was  the  most  common causative  organism as  in  various 
studies world wide. Resistance to ampicillin was present in 30%.
The  incidence  of  anemia  and  preeclampsia  in  both  groups  was 
comparable and this study did not show a cause and effect relationship.
The occurrence of low birth weight infants and preterm delivery 
was reduced similar to that in non-bacteriurics suggesting the importance 
of screening and treatment of ABU during pregnancy.
CONCLUSION
From this study it is concluded that in view of potentially serious 
sequelae of asymptomatic bacteriuria, routine screening of all pregnant 
women at  their  first  prenatal  visit  is  recommended  and that  antibiotic 
treatment and follow up of cases helps in the reduction in the incidence of 
symptomatic  urinary  tract  infections,  preterm  delivery  and  low  birth 
weight infants.
PROFORMA
Name: Age: Occupation:
OP No: Unit: Income:
Address: Religion: Education:
Date of admission: Date of delivery: Date of discharge:
Compliant:
Menstrual H/o
Obstetric H/o Gravida Para LMP EDD
Contraception LVB Last abortion
Past History: Urinary tract infection, hypertension, preeclampsia, diabetes 
mellitus.
Family history : Hypertension, diabetes mellitus, renal disease, CNS, RS.
Obstetric examination:
Laboratory Investigation:
Urine :  protein  sugar microscopy
Urine culture sensitivity colony count
Hb PCV
Blood urea Blood sugar Serum creatinine
Pregnancy outcome Abortion preterm preeclampsia
Mode of delivery preterm labour natural forceps LSCS
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Abbreviation
ABU : Asymptomatic bacteriuria
ARDS
: Adult respiratory distress 
syndrome
CFU : Colony forming unit
E. Coli : Escherichia coli
GBS : Group B streptococcus
GFR : Glomerular filtration rate
Hb : Haemoglobin
HPF : High power field
LE : Leucocyte esterase
PEEP : Positive end expiratory pressure
PET : Preeclampsia
SE Status : Socioeconomic status
SGA : Small for gestational age
UTI : Urinary tract infection
WBC : White blood cell
